Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month

NCT03606642 is registered in ClinicalTrials.gov with HonorHealth Research Institute as lead sponsor.

NCT NCT03606642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03606642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
Lead sponsor
HonorHealth Research Institute
Phase
Phase 2
Overall status
Terminated
Start date
November 19, 2018
Completion date
August 8, 2022
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, stent placement